Recall of Calibrator B from ADVIA Centaur FSH Assay (used with ADVIA Centaur or ADVIA Centaur XP System). An in vitro diagnostic medical device (IVD)

According to Department of Health, Therapeutic Goods Administration, this recall involved a device in Australia that was produced by Siemens Ltd Diagnostics Division.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    RC-2012-RN-00815-3
  • Event Risk Class
    Class II
  • Event Initiated Date
    2012-08-10
  • Event Country
  • Event Source
    DHTGA
  • Event Source URL
  • Notes / Alerts
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • Extra notes in the data
  • Reason
    Siemens confirmed analytical sensitivity values greater than 0.3mlu/ml described in the instructions for use when evaluating multiple lots of the advia centaur fsh assay and calibrator b on the advia centaur and advia centaur xp system.
  • Action
    Siemens is providing work around instructions for users to follow.

Device

  • Model / Serial
    Calibrator B from ADVIA Centaur FSH Assay (used with ADVIA Centaur or ADVIA Centaur XP System). An in vitro diagnostic medical device (IVD)Multiple Ref / Lot numbers & Expiration dates
  • Manufacturer

Manufacturer

  • Manufacturer Parent Company (2017)
  • Source
    DHTGA